Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
153.17
-0.21 (-0.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,071,835
Open
154.20
Bid (Size)
152.90 (200)
Ask (Size)
155.00 (300)
Prev. Close
153.38
Today's Range
152.31 - 154.96
52wk Range
112.34 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal
↗
Today 12:24 EDT
Antares inks Novartis collaboration worth up to $1.9 billion to develop therapies targeting hard-to-treat cancers.
Via
Benzinga
The Quest to Repair What Multiple Sclerosis Takes Away
Today 10:05 EDT
Via
Investor Brand Network
Performance
YTD
+10.6%
+10.6%
1 Month
+1.6%
+1.6%
3 Month
+3.1%
+3.1%
6 Month
+10.1%
+10.1%
1 Year
+30.3%
+30.3%
More News
Read More
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Today 9:55 EDT
Via
Investor Brand Network
Why I Think This Vanguard ETF Will Beat the S&P 500 Over the Next 10 Years
↗
June 20, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
The Quest to Repair What Multiple Sclerosis Takes Away
Today 8:30 EDT
From
BioMedWire
Via
GlobeNewswire
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain?
↗
June 19, 2026
Via
The Motley Fool
Novartis' $12 Billion Bet Pays Off With Encouraging Data From Rare Neuromuscular Disease Study
↗
June 11, 2026
Via
Benzinga
IXUS vs. IEFA: Which International ETF Is Better for Most Investors?
↗
June 10, 2026
Via
The Motley Fool
Topics
ETFs
VXUS Has Delivered Better Returns Than IEFA Over the Past 5 Years. Should It Be in Your Portfolio?
↗
June 09, 2026
Via
The Motley Fool
Topics
ETFs
Arrowhead Pharmaceuticals Lines Up SHASTA Readout as REDEMPLO Launch Gains Traction
↗
June 05, 2026
Via
MarketBeat
IEFA: Why This Fund Is One of the Best International ETFs
↗
June 04, 2026
Via
The Motley Fool
Topics
ETFs
Dry eye syndrome drugs Market Size, Industry Report By 2035
↗
June 04, 2026
Via
Talk Markets
Topics
Economy
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
↗
June 02, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.
↗
June 02, 2026
Via
The Motley Fool
Topics
ETFs
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
↗
June 01, 2026
Via
The Motley Fool
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem
↗
May 27, 2026
Via
The Motley Fool
Topics
ETFs
Pediatrics Medicine Market Size, Industry Report By 2035
↗
May 22, 2026
Via
Talk Markets
Topics
Economy
3 International ETFs for Investors Looking Beyond U.S. Stocks
↗
May 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
↗
May 18, 2026
Via
MarketBeat
Topics
Credit Cards
ETFs
Economy
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials
↗
May 08, 2026
Via
MarketBeat
PTCT Q1 2026 Earnings Transcript
↗
May 08, 2026
Via
The Motley Fool
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
↗
May 06, 2026
Via
Investor's Business Daily
Incyte (INCY) Q2 2025 Earnings Transcript
↗
April 28, 2026
Via
The Motley Fool
Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales
↗
April 28, 2026
Via
Investor's Business Daily
Better Pharma Dividend Stock: Novartis vs. Merck
↗
April 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 153.17
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 06/24/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
